NCT06877156Completed
Local Potential Measurement In PFA: A Pilot Study
Unipolar Signal Local Potential Measurement in Pulsed Field Ablation: A Pilot Study
Source: ClinicalTrials.gov · Last updated 5 Dec 2025
Brief summary (registry, in English)
This is a pilot study to collect unipolar signal data during a pulsed field ablation study for the treatment of atrial fibrillation and to test the performance of an algorithm designed to measure the local potential of the unipolar signal in real time.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 9 (actual)
- First submitted
- 6 Mar 2025
- Start date
- 28 Jul 2025
- Primary completion date
- 30 Jul 2025
- Lead sponsor
- CathVision ApS
- Diseases
- Atrial fibrillation
- NCT number
- NCT06877156
What you commit to
- Study type: Observational
- Participants enrolled: 9
- From 28 Jul 2025 to the primary completion date, 30 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current participation in another investigational drug or device study that interferes with this study.
- Patients who have had a prior ablation procedure
Other illness
- Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements, or impact the scientific soundness of the clinical investigation results.
Other
- Pregnant or nursing subjects.
- Subjects who, in the opinion of the investigator, are not candidates for this study.
- Life expectancy is less than 12 months, in the opinion of the investigator
- Subjects who, in the opinion of the investigator, are considered part of any vulnerable population.
Who the study is looking for
- Subjects with paroxysmal or persistent atrial fibrillation (AF) undergoing first time PFA procedure indicated by investigator for the treatment of atrial fibrillation.
- Male or non-pregnant female aged ≥18 years.
- Able and willing to provide written informed consent prior to any clinical investigation related procedure
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| KBC Split Coordinator of this site? Confirm its status | Split | Croatia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.